Kent Imaging Appoints Jason Nessler as Vice President, Product Development


Jason Nessler, Vice President, Product Development

Kent is pleased to announce Jason Nessler as Vice President, Product Development, with 25 years of experience developing innovative technology solutions.

CALGARY, AB, CANADA, February 1, 2022 / — Kent Imaging is pleased to announce the appointment of Jason Nessler as Vice President, Product Development. Mr. Nessler has over 25 years of leadership experience, including the ability to build consensus and lead diverse cross-functional teams to achieve results.

Mr. Nessler’s leadership experience includes broad responsibilities spanning the creation, management and delivery of technology solutions. At Kent, Mr. Nessler will be responsible for leading product strategy and execution, including software, hardware, cloud and AI solutions.

“The Kent team and Board of Directors are thrilled to have Jason join our organization,” said Pierre Lemire, Kent’s Chief Executive Officer. “The addition of Jason’s senior management to our product development will accelerate our innovation and evolve our engineering processes. Its combination of hardware and software expertise, as well as integration with other systems deployed in cloud infrastructure, positions Kent to continue its technology leadership in support of our mission to reduce hassles and improve outcomes. for patients.

About Kent Imaging, Inc.
Kent Imaging, located in Calgary, Alberta, Canada, is a leading near-infrared tissue oxygenation imaging innovator that develops, manufactures and markets medical technology that supports the management of real-time decision making in wound care, vascular and surgical subspecialties. Kent holds several patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to help healthcare systems nationally and internationally. For more information about Kent Imaging, visit

Sandra Jenks
Kent Imaging Inc.
+1 403-455-7610
write to us here
Visit us on social media:


Comments are closed.